Key result
Higher NT-proBNP is linked to ~35% higher odds of anemia in hospitalized HF.
Why the study?
Anemia is a common comorbidity in patients with HF, but detailed characterization of anemic patients hospitalized with HF remained limited.
Cross-Sectional (n=2,619)
Yes
Anemia affects nearly half (46.4%) of patients hospitalized with heart failure and is independently associated with lower kidney function, higher inflammatory and natriuretic peptide markers, and higher LVEF.
Answers are grounded in this paper and cite their sources.
Anemia is highly prevalent in hospitalized HF; extends comorbidity data but leaves causal and therapeutic implications open for prospective trials.
Background Anemia is a common comorbidity in patients with heart failure (HF), however, detailed characterization of anemic patients with HF remains limited. This study aimed to assess the prevalence and phenotypic characteristics of anemia in a large multicenter cohort of patients hospitalized with HF. Methods A retrospective multicenter observational study included 2,619 adult patients hospitalized with HF. Patients were divided into two groups based on the presence of anemia (defined as hemoglobin < 130 g/L in men and < 120 g/L in women). Data collected included demographics, comorbidities, clinical symptoms, laboratory parameters, ECG, and echocardiography. Multivariable logistic regression was used to identify factors independently associated with anemia. Results Anemia was present in 46.4% of patients, predominantly as normocytic anemia (43.0%). Anemic patients were older (72.4 ± 9.8 vs. 69.5 ± 10.4 years, p < 0.01), had more pronounced signs and symptoms, and were more likely to be in New York Heart Association (NYHA) class IV (59.5% vs. 50.7%, p < 0.01). Anemia was associated with higher prevalence of atrial fibrillation, smaller left ventricular dimensions, and higher E/e’ and right ventricular systolic pressure. In multivariable analysis, lower estimated glomerular filtration rate (OR 0.982, 95% CI 0.975–0.988, p < 0.001), higher log-transformed N-terminal pro-B-type natriuretic peptide (OR 1.349, 95% CI 1.186–1.536, p < 0.001), higher log-transformed C-reactive protein (OR 1.216, 95% CI 1.102–1.342, p < 0.001), and higher left ventricular ejection fraction (OR 1.013, 95% CI 1.000–1.025, p = 0.034) were independently associated with anemia. Conclusion Anemia is highly prevalent among patients hospitalized with HF. The close interplay between anemia, chronic kidney disease, and HF severity underscores the multifactorial nature of anemia in this population.
No takes yet. Share an insight, caveat, or question.
Preveden et al. (2026) conducted a cross-sectional in Heart failure (n=2,619). Anemia (hemoglobin < 130 g/L in men and < 120 g/L in women) vs. Non-anemic patients hospitalized with heart failure was evaluated on Prevalence of anemia and independent clinical factors associated with anemia (such as log-transformed NT-proBNP) (OR 1.349, 95% CI 1.186-1.536, p=<0.001). Anemia was present in 46.4% of patients hospitalized with HF and independently associated with lower eGFR, higher log NT-proBNP, and higher log CRP.
Synapse has enriched 10 related papers. Consider them for comparative context: